Karin Sartorius-Herbst (#1850)
- $ 2 B
- Biopharmaceuticals
- Germany
- F
- 84 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Karin Sartorius-Herbst inherited a stake in Sartorius AG, which makes pharmaceutical an laboratory equipment. Her great-grandfather Florenz Sartorius founded what become Sartorius AG in 1870 to make analytical balances to measure small mass in laboratories. Her father, Horst Sartorius, died in 1998 and left a 50% stake to his daughters Karin, Christine Franken and Ulrike Baro. An executor oversees their inheritance until 2028. Today, the company has more than 15,000 employees and annual revenue exceeding $5 billion. It went public in 1990.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Karin Sartorius-Herbst’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Karin Sartorius-Herbst’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $2.3B
(May 4, 2026)
© Iconic Billionaires